FindMyKOL
Clinical trialNCT00851890CompletedPhase 2Interventional

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

SponsorAbbVie (prior sponsor, Abbott)Enrollment30Chronic Hepatitis C Virus Infection
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study was to assess the safety, tolerability, pharmacokinetics and antiviral activity of ABT-333 (also known as dasabuvir) in treatment-naïve, hepatitis C virus (HCV)-infected participants.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Site Reference Id/investigator# 16182

    Santurce, Puerto Rico

United States
  • Site Reference Id/investigator# 16103

    Anaheim, California, United States

  • Site Reference Id/investigator# 16124

    Los Angeles, California, United States

  • Site Reference Id/investigator# 16102

    Orlando, Florida, United States

  • Site Reference Id/investigator# 16105

    Baton Rouge, Louisiana, United States

  • Site Reference Id/investigator# 16106

    Chapel Hill, North Carolina, United States

  • Site Reference Id/investigator# 16107

    Dallas, Texas, United States

  • Site Reference Id/investigator# 16123

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ABT-333Pegylated interferonRibavirin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2009
Primary completion
31 Jul 2009
Completion
31 Jul 2009
Last update posted
2 Jul 2018
Registered enrollment
30
Registry id
NCT00851890
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.